durvalumab,savolitinib
hutchmed,astrazeneca,orpathys
['calypso', 'durvalumab', 'savolitinib', 'savo']
the #oncoalerttoptweet day 1 #asco22 tweet presents data from calypso trial in clear cell #kidneycancer of savolitinib alone or with durvalumab did not meet the pre specified efficacy endpoint of 50% orr best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??